# Extension Study in Primary Distal Renal Tubular Acidosis

> **NCT03831152** · PHASE3 · WITHDRAWN · sponsor: **Advicenne Pharma**

## Conditions studied

- Acidosis, Renal Tubular

## Interventions

- **DRUG:** ADV7103

## Key facts

- **NCT ID:** NCT03831152
- **Lead sponsor:** Advicenne Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12-20
- **Primary completion:** 2025-01
- **Final completion:** 2025-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No patients enrolled. Study no longer required due to completion of long term safety study in the EU.
- **Last updated:** 2026-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03831152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03831152, "Extension Study in Primary Distal Renal Tubular Acidosis". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03831152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*